Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ong

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Cancer Research Communications|February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsValentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 9, 2019
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forumFred Saad, Christina Canil, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 14, 2021
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providersFred Saad, Sebastien J Hotte, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2020
Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meetingWassim Kassouf, Armen Aprikian, Fred Saad, et al.
Nature Communications|December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancerSoumyajit Roy, Yilun Sun, Maha Hussain, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 26, 2023
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional surveySteven M Yip, Christopher Morash, Michael P Kolinsky, et al.
Nature Communications|February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Cancer Research Communications|February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsValentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 9, 2019
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forumFred Saad, Christina Canil, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 14, 2021
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providersFred Saad, Sebastien J Hotte, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2020
Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meetingWassim Kassouf, Armen Aprikian, Fred Saad, et al.
Nature Communications|December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancerSoumyajit Roy, Yilun Sun, Maha Hussain, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 26, 2023
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional surveySteven M Yip, Christopher Morash, Michael P Kolinsky, et al.
Nature Communications|February 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancerDavid C Müller, Andrew J Murtha, Jack V W Bacon, et al.
Pageof 12